Michael G. Grey, Director at Mirati Therapeutics, Inc. (MRTX), sold 11,220 shares at $65.26 ($732K) on 2019-05-13, disclosed to the SEC on 2019-05-15.
Open-market sale of $732k MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.26 | 5,460 | $356K | 48.6% |
| 2 | $65.26 | 5,460 | $356K | 48.6% |
| 3 | $66.08 | 300 | $20K | 2.7% |
| Total | $65.28 avg | 11,220 | $732K | 100% |
| Filing → |
| MIRM | SELL | 2025-11-25 | $3.5M | — | Filing → |
| MIRM | SELL | 2023-09-14 | $467K | — | Filing → |
| MIRM | SELL | 2023-06-09 | $424K | — | Filing → |